Karen L. Bergman
Investor Relations Kontakt bei BOLT BIOTHERAPEUTICS, INC.
Profil
Karen L.
Bergman is the founder of BCC Partners LLC.
She is currently the Vice President-Communications & Investor Relations at Bolt Biotherapeutics, Inc. Prior to this, she held the same position at ALZA Corp.
and was also the Vice President-Investor Relations & Communications at FibroGen, Inc. Ms. Bergman completed her undergraduate degree at Yale University.
Aktive Positionen von Karen L. Bergman
| Unternehmen | Position | Beginn |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Karen L. Bergman
| Unternehmen | Position | Ende |
|---|---|---|
| BCC Partners LLC | Gründer | - |
| ALZA CORPORATION | Investor Relations Kontakt | - |
| FIBROGEN, INC. | Investor Relations Kontakt | - |
Ausbildung von Karen L. Bergman
| Yale University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| BOLT BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| BCC Partners LLC | |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
